IPW vs REGN · rev $66.1M vs P/E 14, rev $14.34B
iPower Inc (IPW) versus Regeneron Pharmaceuticals Inc (REGN) — a side-by-side from cached financials, not a winner call.
iPower Inc (IPW) is a internet retail company listed on US.
Regeneron Pharmaceuticals Inc (REGN) is a biotechnology company listed on US.
Latest reported IPW revenue for 2025-06-30 was $66.1M. Revenue was down 23.2% from 2024-06-30 to 2025-06-30. IPW currently screens at market cap $20.1M.
Latest reported REGN revenue for 2025-12-31 was $14.34B. Net income was $4.50B. Revenue was up 1.0% from 2024-12-31 to 2025-12-31. REGN currently screens at market cap $59.10B and trailing P/E 13.9.
IPW currently screens at market cap $20.1M. REGN currently screens at market cap $59.10B and trailing P/E 13.9.
Not investment advice. Open the IPW and REGN stock pages for the full models.
Not investment advice.